INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)
Instituto
Claude Bernard University Lyon 1
Villeurbanne, FranciaPublicaciones en colaboración con investigadores/as de Claude Bernard University Lyon 1 (8)
2024
-
Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine
The Lancet Respiratory Medicine, Vol. 12, Núm. 4, pp. 305-322
2020
-
Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial
Neurological Research and Practice, Vol. 2, Núm. 1
2014
2013
-
Application of 'omics technologies to biomarker discovery in inflammatory lung diseases
European Respiratory Journal, Vol. 42, Núm. 3, pp. 802-825
-
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk
PLoS Genetics, Vol. 9, Núm. 3
2012
-
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Human Mutation, Vol. 33, Núm. 4, pp. 690-702
2011
-
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers
Journal of the National Cancer Institute, Vol. 103, Núm. 2, pp. 105-116
2010
-
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Implications for risk prediction
Cancer Research, Vol. 70, Núm. 23, pp. 9742-9754